Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults - Full Text View - ClinicalTrials.gov

Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults<TAB> - Full Text View - ClinicalTrials.gov

Friday, May 17, 2019

Healthy Volunteers Play a Vital Role in Advancing HIV Research

Healthy volunteers play a vital role in advancing HIV research. NIAID researchers at the NIH Clinical Center seek healthy adults ages 18 to 50 years to join a study testing an investigational vaccine targeting HIV. Study participants will not be exposed to HIV so there is no risk of infection. Compensation is provided.